Teva Pharms Drug Patent Portfolio

Teva Pharms's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Teva Pharms News

Teva Reaches Agreement Over Allegations of Hindering Affordable QVAR Alternatives - PYMNTS.com

27 Oct, 2025

3 Drug Companies Selling Generic Drugs Worth Monitoring as Market Conditions Improve - Yahoo Finance

10 Jul, 2024

Teva under investigation by FTC for disputed product patents in the pharmaceutical industry

02 Jul, 2024

FTC Looking Into Teva Regarding Disputed Patents For Inhalers, Reports KFF Health News

02 Jul, 2024

See More